Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2026-05-20 16:15:19 ET · period of report 2026-05-18 · accession 0001104659-26-064516 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-20 16:15 | 2026-05-18 | RYTM | Smith Hunter C | CFO | M - OptEx | $17.87 | +3,000 | 119.6K | +3% | +$53.6K |
| D | 2026-05-20 16:15 | 2026-05-18 | RYTM | Smith Hunter C | CFO | M - OptEx | $0.00 | -3,000 | 79.0K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-18 | M | A | 3,000 | $17.87 | 119,611 | D | — | — | |
| 2 | Derivative | Stock Options (Right to Buy) | 2026-05-18 | M | D | 3,000 | $0.00 | 79,000 | D | $17.87 · — to 2030-02-13 | 3,000 Common Stock | (F1) The options are fully vested. |